CDKN1A and prostate carcinoma: Donor samples deemed to be G2 chromosomal radiosensitive (152 abs/100 meta) were our focus, because although CDKN1A, FDXR and SESN1 were clearly radiation-responsive genes, this was consistently observed in both healthy control and prostate cancer donors.